Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Farber Lipogranulomatosis D055577 1 associated lipids
Niemann-Pick Disease, Type C D052556 1 associated lipids
Sensation Disorders D012678 2 associated lipids
Tachycardia, Sinus D013616 2 associated lipids
Ileus D045823 3 associated lipids
Fabry Disease D000795 4 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Adenomatous Polyps D018256 4 associated lipids
Ovarian Diseases D010049 5 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Pregnancy, Ectopic D011271 5 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Teratocarcinoma D018243 7 associated lipids
Rhabdomyosarcoma D012208 7 associated lipids
Eye Abnormalities D005124 7 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Thrombocythemia, Essential D013920 9 associated lipids
Cardiomyopathies D009202 10 associated lipids
Retinal Detachment D012163 10 associated lipids
Influenza, Human D007251 11 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Lung Injury D055370 14 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Thrombocytopenia D013921 15 associated lipids
Vascular Diseases D014652 16 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Tuberculosis D014376 20 associated lipids
Anemia D000740 21 associated lipids
Sarcoma 180 D012510 21 associated lipids
Hypersensitivity D006967 22 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Fibrosis D005355 23 associated lipids
Pulmonary Edema D011654 23 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Glioblastoma D005909 27 associated lipids
Endotoxemia D019446 27 associated lipids
Neuralgia D009437 28 associated lipids
Insulinoma D007340 28 associated lipids
Proteinuria D011507 30 associated lipids
Acute Lung Injury D055371 33 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Anaphylaxis D000707 35 associated lipids
Acne Vulgaris D000152 35 associated lipids
Heart Failure D006333 36 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Adenoma D000236 40 associated lipids
Arthritis D001168 41 associated lipids
Hyperalgesia D006930 42 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Psoriasis D011565 47 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Asthma D001249 52 associated lipids
Nerve Degeneration D009410 53 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Pain D010146 64 associated lipids
Reperfusion Injury D015427 65 associated lipids
Neuroblastoma D009447 66 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Melanoma D008545 69 associated lipids
Colitis D003092 69 associated lipids
Coronary Disease D003327 70 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Leukemia D007938 74 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Atherosclerosis D050197 85 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Arteriosclerosis D001161 86 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Insulin Resistance D007333 99 associated lipids
Weight Gain D015430 101 associated lipids
Glioma D005910 112 associated lipids
Hypertension D006973 115 associated lipids
Inflammation D007249 119 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hemolysis D006461 131 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Edema D004487 152 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Adenocarcinoma D000230 166 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Che W et al. Corticosteroids inhibit sphingosine 1-phosphate-induced interleukin-6 secretion from human airway smooth muscle via mitogen-activated protein kinase phosphatase 1-mediated repression of mitogen and stress-activated protein kinase 1. 2014 Am. J. Respir. Cell Mol. Biol. pmid:24032470
Chang N et al. Sphingosine 1-phosphate receptors negatively regulate collagen type I/III expression in human bone marrow-derived mesenchymal stem cell. 2014 J. Cell. Biochem. pmid:24038457
Völzke A et al. Sphingosine 1-phosphate (S1P) induces COX-2 expression and PGE2 formation via S1P receptor 2 in renal mesangial cells. 2014 Biochim. Biophys. Acta pmid:24064301
Gorlino CV et al. Neutrophils exhibit differential requirements for homing molecules in their lymphatic and blood trafficking into draining lymph nodes. 2014 J. Immunol. pmid:25015824
Dai L et al. Sphingosine 1-phosphate: a potential molecular target for ovarian cancer therapy? 2014 Cancer Invest. pmid:24499107
Ito K et al. Integrin α9 on lymphatic endothelial cells regulates lymphocyte egress. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:24516133
Takeshita E et al. Diacylglycerol kinase γ is a novel anionic phospholipid binding protein with a selective binding preference. 2014 Biochem. Biophys. Res. Commun. pmid:24486543
Keller J et al. Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts. 2014 Nat Commun pmid:25333900
Lepletier A et al. Early double-negative thymocyte export in Trypanosoma cruzi infection is restricted by sphingosine receptors and associated with human chagas disease. 2014 PLoS Negl Trop Dis pmid:25330249
Bradley E et al. Critical role of Spns2, a sphingosine-1-phosphate transporter, in lung cancer cell survival and migration. 2014 PLoS ONE pmid:25330231
Kim ES et al. Inflammatory lipid sphingosine-1-phosphate upregulates C-reactive protein via C/EBPβ and potentiates breast cancer progression. 2014 Oncogene pmid:23955082
St John AL et al. S1P-Dependent trafficking of intracellular yersinia pestis through lymph nodes establishes Buboes and systemic infection. 2014 Immunity pmid:25238098
Bi Y et al. Sphingosine-1-phosphate mediates a reciprocal signaling pathway between stellate cells and cancer cells that promotes pancreatic cancer growth. 2014 Am. J. Pathol. pmid:25111230
Ishitsuka A et al. FTY720 and cisplatin synergistically induce the death of cisplatin-resistant melanoma cells through the downregulation of the PI3K pathway and the decrease in epidermal growth factor receptor expression. 2014 Int. J. Mol. Med. pmid:25109763
Rolin J and Maghazachi AA Implications of chemokines, chemokine receptors, and inflammatory lipids in atherosclerosis. 2014 J. Leukoc. Biol. pmid:24493826
Tsai YC et al. Antiapoptotic agent sphingosine-1-phosphate protects vitrified murine ovarian grafts. 2014 Reprod Sci pmid:23793475
Snelder N et al. Translational pharmacokinetic modeling of fingolimod (FTY720) as a paradigm compound subject to sphingosine kinase-mediated phosphorylation. 2014 Drug Metab. Dispos. pmid:24965813
Tarbell JM et al. Mechanosensing at the vascular interface. 2014 Annu Rev Biomed Eng pmid:24905872
Smyth SS et al. Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis. 2014 Arterioscler. Thromb. Vasc. Biol. pmid:24482375
Takabe K and Spiegel S Export of sphingosine-1-phosphate and cancer progression. 2014 J. Lipid Res. pmid:24474820
Borge M et al. The expression of sphingosine-1 phosphate receptor-1 in chronic lymphocytic leukemia cells is impaired by tumor microenvironmental signals and enhanced by piceatannol and R406. 2014 J. Immunol. pmid:25127862
Jensen T et al. The identification of GPR3 inverse agonist AF64394; the first small molecule inhibitor of GPR3 receptor function. 2014 Bioorg. Med. Chem. Lett. pmid:25442311
Lee H et al. 4-Deoxypyridoxine improves the viability of isolated pancreatic islets ex vivo. 2013 May-Jun Islets pmid:23756681
Egom EE et al. Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy. 2013 May-Jun Crit Rev Clin Lab Sci pmid:23885725
Ratajczak MZ et al. An emerging link in stem cell mobilization between activation of the complement cascade and the chemotactic gradient of sphingosine-1-phosphate. 2013 Jul-Aug Prostaglandins Other Lipid Mediat. pmid:22981511
Morozov VI et al. Sphingosine-1-phosphate: distribution, metabolism and role in the regulation of cellular functions. 2013 Jan-Feb Ukr Biokhim Zh (1999) pmid:23534286
Garris CS et al. Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. 2013 Nat. Immunol. pmid:24076635
Bot M et al. Hematopoietic sphingosine 1-phosphate lyase deficiency decreases atherosclerotic lesion development in LDL-receptor deficient mice. 2013 PLoS ONE pmid:23700419
Arce FT et al. Heterogeneous elastic response of human lung microvascular endothelial cells to barrier modulating stimuli. 2013 Nanomedicine pmid:23523769
Southern C et al. Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors. 2013 J Biomol Screen pmid:23396314
Brewer JW Phospholipids: "greasing the wheels" of humoral immunity. 2013 Biochim. Biophys. Acta pmid:23051607
Mierzejewska K et al. Sphingosine-1-phosphate-mediated mobilization of hematopoietic stem/progenitor cells during intravascular hemolysis requires attenuation of SDF-1-CXCR4 retention signaling in bone marrow. 2013 Biomed Res Int pmid:24490172
Beckham TH et al. Acid ceramidase promotes nuclear export of PTEN through sphingosine 1-phosphate mediated Akt signaling. 2013 PLoS ONE pmid:24098536
Xiong Y et al. Sphingosine kinases are not required for inflammatory responses in macrophages. 2013 J. Biol. Chem. pmid:24081141
Karimian G et al. Sphingosine kinase-1 inhibition protects primary rat hepatocytes against bile salt-induced apoptosis. 2013 Biochim. Biophys. Acta pmid:23816565
Liu Y et al. Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine 1-phosphate receptors. 2013 J. Pathol. pmid:23839903
Riccitelli E et al. Extracellular sphingosine-1-phosphate: a novel actor in human glioblastoma stem cell survival. 2013 PLoS ONE pmid:23826381
Wang Y et al. Epidermal growth factor receptor signaling-dependent calcium elevation in cumulus cells is required for NPR2 inhibition and meiotic resumption in mouse oocytes. 2013 Endocrinology pmid:23787120
Camprubí-Robles M et al. Sphingosine-1-phosphate-induced nociceptor excitation and ongoing pain behavior in mice and humans is largely mediated by S1P3 receptor. 2013 J. Neurosci. pmid:23392686
Yasuo M et al. Fenretinide causes emphysema, which is prevented by sphingosine 1-phoshate. 2013 PLoS ONE pmid:23326540
Kim YD et al. Effects of sphingosine-1-phosphate on pacemaker activity of interstitial cells of Cajal from mouse small intestine. 2013 Mol. Cells pmid:23307289
Sharma N et al. Sphingosine-1-phosphate suppresses TLR-induced CXCL8 secretion from human T cells. 2013 J. Leukoc. Biol. pmid:23345392
Salvemini D et al. Therapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in pain. 2013 Trends Pharmacol. Sci. pmid:23318139
Véret J et al. Role of palmitate-induced sphingoid base-1-phosphate biosynthesis in INS-1 β-cell survival. 2013 Biochim. Biophys. Acta pmid:23085009
Koch A et al. Sphingosine 1-phosphate in renal diseases. 2013 Cell. Physiol. Biochem. pmid:23736205
Huang LS et al. Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis. 2013 FASEB J. pmid:23315259
Fukuhara S and Mochizuki N [Lymphocytes mobilization into blood regulated by Spns2, a sphingosine 1-phosphate transporter, expressed on endothelial cells]. 2013 Seikagaku pmid:23717873
O'Sullivan C and Dev KK The structure and function of the S1P1 receptor. 2013 Trends Pharmacol. Sci. pmid:23763867
Chang CH et al. Sphingosine-1-phosphate induces VEGF-C expression through a MMP-2/FGF-1/FGFR-1-dependent pathway in endothelial cells in vitro. 2013 Acta Pharmacol. Sin. pmid:23377549
Cuvillier O et al. Hypoxia, therapeutic resistance, and sphingosine 1-phosphate. 2013 Adv. Cancer Res. pmid:23290779